COMP <GO>
VENU vs CPHC // EV/EBITDA & P/E VALUATION
Venu Holding Corporation (NYSE) VS. Canterbury Park Holding Corporation 'New' (NASDAQ) • 15-METRIC TALLY: VENU 2
— CPHC 3
■ METRIC PARITY
LAST: $1.40 (+3.70%) • MKT CAP: $82.4M
valuation
—
LAST: $15.66 (-0.38%) • MKT CAP: $81.2M
valuation
28.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VENU VS. CPHC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VENU | CPHC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.10% | 2.70% | -33.80 | CPHC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 28.1x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | 10.96% | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 0.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.76% | -1.76 | CPHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | CPHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.5 | 48.4 | +14.06 | VENU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $82.4M | $81.2M | $1.2M | VENU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VENU REV | CPHC REV | VENU GROSS % | CPHC GROSS % | VENU FCF | CPHC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.9M | $0 | — | — | -$134.0M | $8.9M |
| FY 2024 | $17.8M | $0 | — | — | -$68.7M | $6.5M |
| FY 2023 | $12.6M | $0 | — | — | -$4.9M | $11.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VENU // BETA —
CPHC // BETA —